Marina Kristy Ibraheim

Dr. Marina Kristy Ibraheim


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Dermatopathology
Verified
Journal Article
Open access
PDF file
Marina Kristy IbraheimMarina Kristy Ibraheim
Marina Kristy Ibraheim
RGRohit Gupta
Rohit Gupta
JGJerad M. Gardner
Jerad M. Gardner
Ashley ElsensohnAshley Elsensohn
Ashley Elsensohn
In recent years, researchers have explored potential uses for artificial intelligence (AI) in medical practice

30 April 2024 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
Marina Kristy IbraheimMarina Kristy Ibraheim
Marina Kristy Ibraheim
Jeffrey P. NorthJeffrey P. North
Jeffrey P. North

8 September 2023 in Dermatology Online Journal
Verified
Journal Article
Open access
PDF file
Marina Kristy IbraheimMarina Kristy Ibraheim
Marina Kristy Ibraheim
AEAshley Elsensohn
Ashley Elsensohn
CHChristopher Hauschild
Christopher Hauschild
AHAnthony Hilliard
Anthony Hilliard
HDHarry Dao
Harry Dao
In recent months, the general public has become more cognizant of the potential of oral minoxidil to promote hair growth; this was promulgated, in part, by an article published in the New York Times entitled, "An Old Medicine Grows New Hair for Pennies a Day, Doctors Say." Minoxidil was added to the pharmacologic armamentarium as an antihypertensive nearly 60 years ago and was found to trigger hypertrichosis in many patients, but its use dropped sharply as cardiologists observed a number of adverse cardiovascular events including ischemic heart disease, left ventricular hypertrophy, pleural effusions, and pericardial effusions. Studies in the realm of dermatology have explored the utility and safety of low dose oral minoxidil (LDOM) for management of alopecia. This article highlights potential clinical conundrums posed by these rare but severe cardiovascular complications and the importance of collaboration between cardiologists and dermatologists when employing this agent in patients with cardiorenal or cardiovascular risk factors.

2 May 2023 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
Marina Kristy IbraheimMarina Kristy Ibraheim
Marina Kristy Ibraheim
MDMansee Desai
Mansee Desai
MTMelanie Tawfik
Melanie Tawfik
AEAshley Elsensohn
Ashley Elsensohn
BFBetsy Furukawa
Betsy Furukawa
Microblading is a common cosmetic procedure that can modify the appearance of one's eyebrows. Although generally well-tolerated, the procedure can cause a number of dermatologic issues; on rare occasions, granulomatous reactions can manifest. We use this case to highlight a presentation of a nonsarcoidal granulomatous dermatitis and review the literature on granulomatous reactions secondary to microblading. Of the 21 cases included in our review, approximately half (10/21) were diagnosed with foreign-body granulomas and the other half with sarcoidosis (7 of 21 with systemic sarcoidosis and 4 of 21 with cutaneous sarcoidosis). Although microblading remains a commonplace cosmetic technique, it is not without risk. Much like other types of tattoos, microblading can cause granulomatous reactions for which we must be vigilant, and further workup for sarcoidosis might be considered in select patients.

12 August 2024 in Dermatopathology
Verified
Journal Article
Open access
PDF file
JPJohannes Pawlowski
Johannes Pawlowski
Tatsiana PukhalskayaTatsiana Pukhalskaya
Tatsiana Pukhalskaya
KCKelly Cordoro
Kelly Cordoro
Marina Kristy IbraheimMarina Kristy Ibraheim
Marina Kristy Ibraheim
Jeffrey P. NorthJeffrey P. North
Jeffrey P. North
Netherton syndrome (NS) is a rare autosomal recessive disorder that occurs due to a loss-of-function mutation in SPINK5; this loss results in significant inflammation, as well as perturbations of the skin barrier’s integrity and functionality. While it is unclear which inflammatory pathways contribute to the development of NS, recent studies have demonstrated the expression of interleukin (IL)-17/IL-36, as well as several Th2 cytokines. Consequently, immunohistochemistry (IHC) with IL-36 may serve as a potential tool for aiding the histopathological diagnosis of this condition. In this case series, we present two cases of NS and capture their immunostaining pattern with IL-36. Both cases demonstrated robust expression of IL-36. This finding bolsters the hypothesis that NS is partially driven by Th17 activation and suggests the potential utility of IL-36 IHC as part of the workup for this rare and diagnostically elusive entity. LEKTI IHC was negative in one biopsy, revealing a limitation of this stain in diagnosing NS.

6 June 2024 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
Marina Kristy IbraheimMarina Kristy Ibraheim
Marina Kristy Ibraheim
MTMichael T. Tetzlaff
Michael T. Tetzlaff
Jeffrey P. NorthJeffrey P. North
Jeffrey P. North